Endocannabinoid tone versus constitutive activity of cannabinoid receptors. - Test2 - elhamkhani - TriplyDB

Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

http://www.wikidata.org/entity/Q35193265

about

Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugs Anandamide externally added to lipid vesicles containing trapped fatty acid amide hydrolase (FAAH) is readily hydrolyzed in a sterol-modulated fashion Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?Crystallographic study of FABP5 as an intracellular endocannabinoid transporter The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors Endogenous cannabinoid signaling at inhibitory interneurons.Chronic ethanol alters network activity and endocannabinoid signaling in the prefrontal cortex.Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell.Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD).JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.Polarized cellular patterns of endocannabinoid production and detection shape cannabinoid signaling in neurons Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors.Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoE-Deficient Mice Cannabinoid receptors: nomenclature and pharmacological principles A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates.Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs).Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists.The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease.The therapeutic potential of the endocannabinoid system for Alzheimer's disease.Type-1 cannabinoid receptor signaling in neuronal development.Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function.Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.The cannabinoid system and pain.CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities.Endocannabinoid 2-arachidonylglycerol protects primary cultured neurons against homocysteine-induced impairments in rat caudate nucleus through CB1 receptor.N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities.Themed issue on cannabinoids in biology and medicine.Song-associated reward correlates with endocannabinoid-related gene expression in male European starlings (Sturnus vulgaris).The Antinociceptive Agent SBFI-26 Binds to Anandamide Transporters FABP5 and FABP7 at Two Different Sites.Regulation of cannabinoid CB2 receptor constitutive activity in vivo: repeated treatments with inverse agonists reverse the acute activation of JNK and associated apoptotic signaling in mouse brain.Activation of type-1 cannabinoid receptor shifts the balance between excitation and inhibition towards excitation in layer II/III pyramidal neurons of the rat prelimbic cortex.Elevated levels of 2-arachidonoylglycerol promote atherogenesis in ApoE-/- mice.Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter.

P2860

Q21090468-7A9BAD93-D661-42E2-9411-0C25811C042B Q21090833-2983B91C-CF4A-4078-9684-E01FA8956D1A Q24598965-E8AEB85A-BC3D-48BB-A9C8-04B59F4CF8A2 Q27025612-7D4A1630-3BC4-44EC-982F-D015CD47A50F Q27681752-65F047CB-1CF9-491A-BE62-3356B52337A5 Q30486707-66D96093-E6B8-49B3-94E1-7D2253F0CF96 Q33624983-DB193A80-49EE-459C-AE0C-A095D6DA756C Q33919028-40BD0251-8D76-4843-8C42-376BDD8194A6 Q34359778-6CEEE695-F8F8-4645-B65B-9424A69E638F Q34461976-FE1D3E32-7DC6-4008-B110-7E2BF5C2198B Q34715335-4A2FEA26-7E34-4915-A185-B2130AC161ED Q34840647-D0F9CEB4-EC91-4669-8847-7B6168465C9E Q35728434-AEE2BFA3-6C53-40EA-BFB1-5034C196A2C8 Q35885485-FEF3E792-A83E-4E17-8D97-8A7B5EDC47BD Q36044310-AB326B89-1889-41FC-810C-A34D07EB2FE1 Q36368922-41DDB91D-8EFC-49F0-9DDF-306A995F1D5D Q36637155-33210CE9-4624-4A93-A49D-7042AF6D06FF Q37335452-4A1F8E9F-8F7D-4B77-836C-67134FB7ADE1 Q37984087-3145DBE3-FE74-4FAF-9EA1-863CFA1C3B91 Q37988405-6FB3179D-C338-49F8-95C3-200A5463CA49 Q37997020-4E8EB86F-BBEC-44F1-B80A-F197A695D7E5 Q38024934-03CC8636-61E0-43EC-B0AA-E4DDE6A7A420 Q38520997-287D1C81-E31B-4638-B7F1-1EF56DE63E2C Q38636791-7F19E300-13C2-4353-A244-8914FAC74721 Q38669685-9773691A-6051-464C-A3AD-6389174C22AE Q38777382-63DDE5CE-45EE-4171-97EA-8BA6140550F1 Q39319839-D63417C4-1025-4E01-A1C8-EB90BA391997 Q42461874-89F4480B-602A-4142-A7A3-FFAAE8375CE9 Q42714635-7FACB920-1F39-4608-86BC-80B4D6C08F1A Q45323350-7963CA19-5786-4E0E-927A-3609D0AAA790 Q46424750-22180502-1FFE-494B-9BA6-DAD0A20AC1AD Q47794981-22AB9EB4-2543-4B4A-BBD4-7B5AEE2EAD56 Q48337573-10CD651A-2783-478E-A9EC-CBB5F1A65353 Q48626643-546B34D7-37D3-487C-B763-875CD5910B63 Q55003361-03AC8B7A-58FD-435C-8A24-AEDAF406E6D0 Q55443804-B22E200B-0C95-4951-9C62-59431ABCDC55

P2860

Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

http://www.wikidata.org/entity/Q35193265

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

@ast

Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

@en

type

label

Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

@ast

Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

@en

prefLabel

Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

@ast

Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

@en

P1433

Q35193265-CF75DF99-3D21-4F66-8C5F-ACC7A9507976

P1476

Q35193265-9C5C1E3C-5CE0-4CCF-A588-692B36A0914E

P2093

Q35193265-537C7DE9-C206-48B7-ACF0-7BB618AF5C42

Q35193265-B862E0D7-0362-4F3E-8BC0-6F61C69D71EA

Q35193265-C67F991C-9E7C-45D4-A71B-563B8C579E41

Q35193265-E8E8F955-A9D5-425E-AF87-8F566D5C2F37

Q35193265-E92FE590-17DD-43F7-8957-4F0EA09CDD05

Q35193265-EBFB85AD-D982-4A63-B83B-8D71D0BC77FF

P2860

Q35193265-007C100B-B4E0-4C61-882A-555D6695413B

Q35193265-04E6B85D-60FA-4D62-B22B-1BE6BF096665

Q35193265-07345DB0-FE27-428B-8962-1BE541AC24E0

Q35193265-0A7F1257-FB00-49E0-9118-BF12318D7193

Q35193265-0B9D9D93-C6F3-4E52-9910-CCB1790AD654

Q35193265-0F265C4D-3362-44E4-BA42-9D4E87D43A41

Q35193265-0F2E3986-C1D4-4933-9762-0866829B38CF

Q35193265-119ABA2D-47AA-4D0B-849E-19C86D9CEF50

Q35193265-134C2541-100E-4424-9640-68484A673704

Q35193265-151CF560-2F32-4DFA-BB76-815E10FE151C

P304

Q35193265-BA843AE6-DD21-400F-ACFE-EB07679EC942

P31

Q35193265-45036E8A-CABC-4906-93D6-90D6404D6EAB

P356

Q35193265-A6AAC764-7C0B-418A-A5C5-A1B63A228020

P407

Q35193265-EC50C9CD-4652-43C4-893E-30E4C84FFB04

P433

Q35193265-97C0BBAC-C4FB-4768-8038-3A6150A25271

P478

Q35193265-6D1B835C-6211-472F-BA1D-87D14E1CCE01

P577

Q35193265-BB030099-AD79-4783-9CFC-B178A57057C9

P5875

Q35193265-0F2D2E97-7CB7-4B10-AB6A-0C5982853421

P698

Q35193265-072C4083-7D08-42F1-8A91-AD9A90EE93B7

P921

Q35193265-04D85572-D18B-4DFE-A631-A87E9EE4BE60

Q35193265-1ebcb84a-dd76-4bca-a6f0-2246b4d44019

Q35193265-3E37530E-CDD5-42D9-95DA-ABDD57BE8938

Q35193265-6B09AE20-9CAD-4E12-9866-197F7F61C20B

P932

Q35193265-84A2749A-5D53-46D8-8339-F0FF0169E0DB

P356

J.1476-5381.2011.01364.X

P1433

British Journal of Pharmacology

P1476

Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

@en

P2093

Allyn C Howlett

http://www.w3.org/2001/XMLSchema#string

Dale G Deutsch

http://www.w3.org/2001/XMLSchema#string

Nadine M Ulloa

http://www.w3.org/2001/XMLSchema#string

Patricia H Reggio

http://www.w3.org/2001/XMLSchema#string

Robert E Hampson

http://www.w3.org/2001/XMLSchema#string

Steven R Childers

http://www.w3.org/2001/XMLSchema#string

P2860

Brain monoglyceride lipase participating in endocannabinoid inactivation

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors

Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717

A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol

The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist

High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor

Identification of intracellular carriers for the endocannabinoid anandamide

A biosynthetic pathway for anandamide

Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids

P304

1329-1343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2011.01364.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

163

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51101009

http://www.w3.org/2001/XMLSchema#string

P698

21545414

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoid receptor

endocannabinoids

P932

3165945

http://www.w3.org/2001/XMLSchema#string